Interpace Biosciences, Inc.
IDXG
$0.95
$0.077.35%
OTC PK
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 1.42M | 502.00K | 1.20M | 1.46M | 2.11M |
| Total Receivables | 5.97M | 7.23M | 8.77M | 8.54M | 7.29M |
| Inventory | 1.10M | 973.00K | 1.21M | 1.21M | 1.22M |
| Prepaid Expenses | 584.00K | 730.00K | 397.00K | 535.00K | 441.00K |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 53.00K | 68.00K | 84.00K | 22.00K | 43.00K |
| Total Current Assets | 9.13M | 9.50M | 11.65M | 11.77M | 11.11M |
|
|
|||||
| Total Current Assets | 9.13M | 9.50M | 11.65M | 11.77M | 11.11M |
| Net Property, Plant & Equipment | 2.86M | 2.79M | 2.80M | 2.97M | 2.88M |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 45.00K | 45.00K | 45.00K | 45.00K | 45.00K |
| Total Assets | 12.04M | 12.34M | 14.49M | 14.79M | 14.04M |
|
|
|||||
| Total Accounts Payable | 1.41M | 1.25M | 1.73M | 1.66M | 1.70M |
| Total Accrued Expenses | 2.26M | 2.84M | 2.84M | 3.33M | 10.16M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 1.40M | 2.18M | 3.16M | 4.67M | 5.99M |
| Total Finance Division Other Current Liabilities | 881.00K | 883.00K | 950.00K | 957.00K | 919.00K |
| Total Other Current Liabilities | 881.00K | 883.00K | 950.00K | 957.00K | 919.00K |
| Total Current Liabilities | 5.95M | 7.15M | 8.68M | 10.62M | 18.77M |
|
|
|||||
| Total Current Liabilities | 5.95M | 7.15M | 8.68M | 10.62M | 18.77M |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 864.00K | 974.00K | 1.08M | 1.18M | 1.19M |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 5.53M | 5.43M | 5.32M | 5.21M | 5.23M |
| Total Liabilities | 12.33M | 13.55M | 15.08M | 17.01M | 25.19M |
|
|
|||||
| Common Stock & APIC | 235.24M | 235.23M | 235.22M | 235.22M | 188.77M |
| Retained Earnings | -233.46M | -234.37M | -233.73M | -235.38M | -244.41M |
| Treasury Stock & Other | -2.07M | -2.07M | -2.07M | -2.05M | -2.05M |
| Total Common Equity | -298.00K | -1.21M | -582.00K | -2.22M | -57.68M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | 46.54M |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | 46.54M |
|
|
|||||
| Total Common Equity | -298.00K | -1.21M | -582.00K | -2.22M | -57.68M |
| Total Preferred Equity | -- | -- | -- | -- | 46.54M |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -298.00K | -1.21M | -582.00K | -2.22M | -11.15M |
|
|
|||||